Skip to main content
Equibles

Frank D. Lee

CEO

Pacira BioSciences, Inc. (PCRX)

Board Member

Pacira BioSciences, Inc. (PCRX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Frank D. Lee

Frank D. Lee is recorded as CEO and Board Member at Pacira BioSciences, Inc. (PCRX). Earlier roles on record: Board Member at Bolt Biotherapeutics, Inc. (BOLT) until September 3, 2024. Pacira BioSciences, Inc. reported in an 8-K filed June 13, 2025 that Frank D. Lee was appointed Class II director, effective June 10, 2025. Bolt Biotherapeutics, Inc. reported in an 8-K filed September 4, 2024 that Frank D. Lee resigned as member of the Board, effective September 3, 2024. Pacira BioSciences, Inc. reported in an 8-K filed December 21, 2023 that Frank D. Lee was appointed member of the Board, effective January 2, 2024. Equibles holds 4 filed executive changes naming Frank D. Lee; each is listed under recent activity with its source filing.

“Election of three Class II directors to hold office until the 2028 annual meeting of stockholders, and until their respective successors have been duly elected and qualified.”
Pacira BioSciences, Inc. Form 8-K, filed June 13, 2025 · Read the filing
“On September 1, 2024, Frank D. Lee notified the Company of his resignation as a member of the Board and the committees thereof, effective as of September 3, 2024.”
Bolt Biotherapeutics, Inc. Form 8-K, filed September 4, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Pacira BioSciences, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.